Adaptive Biotechnologies chief commercial officer Susan Bobulsky sells 6,444 shares for $193,320
ADPT•Susan Bobulsky sold 6,444 Adaptive Biotechnologies shares on Oct. 6, 2026, at $30 per share, leaving her with 389,350 shares.
1. Share sale
Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky sold 6,444 common shares on Oct. 6, 2026, at $30 per share. Her holdings fell to 389,350 shares following the transaction.
